08:00 , Feb 13, 2014 |  BC Innovations  |  Distillery Techniques

Technology: Drug platforms

This week in techniques Approach Summary Licensing status Publication and contact information Drug platforms Systematic evolution of ligands by exponential enrichment (SELEX) incorporating artificially expanded genetic information systems (AEGIS) nucleotides SELEX using AEGIS-incorporating libraries could...
07:00 , May 5, 2008 |  BioCentury  |  Strategy

Buying biology

Buying biology Completed Acquired company Acquirer Value Biology focus 2006 Sirna Merck (NYSE:MRK) $1,100 RNAi 2008 Sirtris (NASDAQ:SIRT) GlaxoSmithKline (LSE:GSK; NYSE:GSK) $720 Sirtuins 2007 Adnexus Bristol-Myers (NYSE:BMY) $505 Protein engineering 2007 Domantis GlaxoSmithKline (LSE:GSK; NYSE:GSK)...
07:00 , Aug 21, 2006 |  BC Week In Review  |  Company News

Cadence management update

Cadence Pharmaceuticals Inc. , San Diego, Calif.   Business: Infectious   Hired: James Breitmeyer as EVP of development and CMO, formerly CMO of Eli Lilly and Co. 's Applied Molecular Evolution Inc. subsidiary  ...
00:35 , Aug 15, 2006 |  BC Extra  |  Company News

Cadence names Breitmeyer CMO

Infectious disease and pain company Cadence (San Diego, Calif.) hired James Breitmeyer as CMO and EVP of development. He was most recently CMO at Applied Molecular Evolution, a subsidiary of Eli Lilly (LLY)....
07:00 , Sep 26, 2005 |  BC Week In Review  |  Company News

MorphoSys, Eli Lilly combinatorial biology news

LLY and MOR entered into a cross licensing agreement that settles a 2001 patent infringement suit. LLY granted MOR a license to generate and screen LLY's recombinant peptide and protein libraries and to commercialize any...
07:00 , Jun 27, 2005 |  BioCentury  |  Emerging Company Profile

Corporate Profile

Novasite Pharmaceuticals Inc. San Diego, Calif. Technology: Allosteric modulation of GPCRs Disease focus: Neurology Clinical status: Preclinical Founded: 2000 by Juan Ballesteros, Michael Freedman and William Huse, as a spinout from Applied Molecular Evolution Inc....
07:00 , Jun 27, 2005 |  BioCentury  |  Emerging Company Profile

Novasite: Conceptually quick

Allosteric modulators, which modify ligand-induced receptor activity by binding at a site distinct from that of the native ligand, are attractive because their effect should be confined to tissues where the natural ligand and its...
00:17 , Jun 8, 2005 |  BC Extra  |  Company News

Novasite names Harris CEO

Novasite (San Diego, Calif.) hired Tim Harris as president and CEO. He replaces interim CEO William Huse, who is president/site head of Eli Lilly (LLY) subsidiary Applied Molecular Evolution. Previously, Harris was CEO of cancer...
08:00 , Feb 7, 2005 |  BC Week In Review  |  Company News

MorphoSys, Eli Lilly combinatorial biology news

LLY subsidiary Applied Molecular Evolution Inc. (San Diego, Calif.) said a judge on the U.S. District Court for the District of Massachusetts denied all motions for a summary judgment in a patent infringement suit against...
08:00 , Feb 1, 2005 |  BC Extra  |  Company News

MorphoSys/Eli Lilly suit to continue

LLY subsidiary Applied Molecular Evolution said a judge on the U.S. District Court for the District of Massachusetts denied all motions for a summary judgment in a patent infringement suit against MorphoSys (FSE:MOR). The suit...